175 related articles for article (PubMed ID: 1678580)
21. Effect of celiprolol on large and small arteries of the forearm circulation in hypertensive patients.
Roman O; Meza N; Klenner C
Cardiovasc Drugs Ther; 1990 Jun; 4(3):745-9. PubMed ID: 2150174
[TBL] [Abstract][Full Text] [Related]
22. Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients.
Doshan HD; Rosenthal RR; Brown R; Slutsky A; Applin WJ; Caruso FS
J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S105-8. PubMed ID: 2427836
[TBL] [Abstract][Full Text] [Related]
23. Acute haemodynamic profile of celiprolol in patients with coronary heart disease and hypertension: a double-blind comparison with metoprolol.
Heublein B; Modersohn D; Franz N; Panzner B
Eur Heart J; 1991 May; 12(5):617-23. PubMed ID: 1678705
[TBL] [Abstract][Full Text] [Related]
24. A predictive model of the health benefits and cost effectiveness of celiprolol and atenolol in primary prevention of cardiovascular disease in hypertensive patients.
Milne RJ; Vander Hoorn S; Jackson RT
Pharmacoeconomics; 1997 Sep; 12(3):384-408. PubMed ID: 10170463
[TBL] [Abstract][Full Text] [Related]
25. Celiprolol in hypertension.
Taylor SH
Am Heart J; 1988 Nov; 116(5 Pt 2):1426-34. PubMed ID: 2903654
[TBL] [Abstract][Full Text] [Related]
26. Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease.
Fogari R; Zoppi A; Tettamanti F; Poletti L; Rizzardi G; Fiocchi G
Cardiovasc Drugs Ther; 1990 Aug; 4(4):1145-9. PubMed ID: 1982059
[TBL] [Abstract][Full Text] [Related]
27. Systemic and renal hemodynamic effects of celiprolol in essential hypertensives.
Lucarini AR; Salvetti A
Am J Cardiol; 1988 Feb; 61(5):45C-48C. PubMed ID: 2963525
[TBL] [Abstract][Full Text] [Related]
28. Celiprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties and its therapeutic use in hypertension and angina pectoris.
Riddell JG; Shanks RG; Brogden RN
Drugs; 1987 Oct; 34(4):438-58. PubMed ID: 2890513
[TBL] [Abstract][Full Text] [Related]
29. Celiprolol and verapamil in the treatment of essential hypertension.
McInnes GT; McLenachan JM; Henderson E; Herrick AL; Dargie HJ
Am Heart J; 1988 Nov; 116(5 Pt 2):1437-8. PubMed ID: 2903656
[No Abstract] [Full Text] [Related]
30. Celiprolol in angina pectoris.
Soberman JE; Frishman WH
Am Heart J; 1988 Nov; 116(5 Pt 2):1422-5. PubMed ID: 2903653
[TBL] [Abstract][Full Text] [Related]
31. Antihypertensive therapy with celiprolol: a new cardioselective beta blocker.
Norris RJ
Am J Cardiol; 1988 Feb; 61(5):14C-22C. PubMed ID: 2893531
[TBL] [Abstract][Full Text] [Related]
32. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
Leenen FH; Davies RA; Fourney A
Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
[TBL] [Abstract][Full Text] [Related]
33. The effect of celiprolol on the blood lipid profile in hypertensive patients with high cholesterol levels.
Fogari R; Zoppi A; Tettamanti F; Malamani G; Pasotti C
Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1287-90. PubMed ID: 1826213
[TBL] [Abstract][Full Text] [Related]
34. Hemodynamic interactions of a new beta blocker, celiprolol, with nifedipine in angina pectoris.
Silke B; Verma SP; Guy S
Cardiovasc Drugs Ther; 1991 Aug; 5(4):681-7. PubMed ID: 1679661
[TBL] [Abstract][Full Text] [Related]
35. Peripheral hemodynamic effects of short-term nadolol administration in essential hypertension.
Levenson J; Simon AC; Moyse D; Bouthier J; Safar ME
Am Heart J; 1984 Oct; 108(4 Pt 2):1177-82. PubMed ID: 6148882
[TBL] [Abstract][Full Text] [Related]
36. [Acute changes of coronary and global hemodynamics in patients with angina pectoris and arterial hypertension caused by celiprolol and metoprolol].
Franz N; Modersohn D; Linss G; Heublein B; Gola G; Bruch L; Walde T
Radiol Diagn (Berl); 1990; 31(6):625-8. PubMed ID: 1982742
[TBL] [Abstract][Full Text] [Related]
37. Celiprolol--overview of 6 years of clinical trials experience.
Pruss TP; Lamon KD; Hagen NS
J Int Med Res; 1988; 16 Suppl 1():17A-22A. PubMed ID: 2906015
[TBL] [Abstract][Full Text] [Related]
38. A long-term study of the effects of celiprolol on blood pressure and lipid-associated risk factors.
Herrmann JM; Mayer EO
Am Heart J; 1988 Nov; 116(5 Pt 2):1416-21. PubMed ID: 2903652
[TBL] [Abstract][Full Text] [Related]
39. Acute hemodynamic effects of beta-blockers in patients with severe congestive heart failure: comparison of celiprolol and esmolol.
Felix SB; Stangl V; Kieback A; Doerffel W; Staudt A; Wernecke KD; Baumann G; Stangl K
J Cardiovasc Pharmacol; 2001 Nov; 38(5):666-71. PubMed ID: 11602813
[TBL] [Abstract][Full Text] [Related]
40. Comparison of ketanserin and celiprolol on regression of left ventricular hypertrophy in older hypertensive patients.
Vyssoulis GP; Karpanou EA; Pitsavos CE; Kourtis TK; Paleologos AA; Toutouzas PK
Cardiovasc Drugs Ther; 1992 Aug; 6(4):419-24. PubMed ID: 1355664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
